Skeletal Muscle SIRT1 and the Genetics of Metabolic Health: Therapeutic Activation by Pharmaceuticals and Exercise

Overview

Journal Appl Clin Genet

Publisher Dove Medical Press

Specialty Genetics

Date 2013 Jun 19

PMID 23776383

Citations 12

Authors

Cameron B Williams

Brendon J Gurd

Affiliations

Soon will be listed here.

Abstract

Silent mating type information regulation 2 homolog 1 (SIRT1) is implicated in the control of skeletal muscle mitochondrial content and function through deacetylation of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and participation in the SIRT1/PGC-1α axis. The SIRT1/PGC-1α axis control of skeletal muscle mitochondrial biogenesis is an important therapeutic target for obesity and obesity-related metabolic dysfunction, as skeletal muscle mitochondrial dysfunction is implicated in the pathogenesis of multiple metabolic diseases. This review will establish the importance of the SIRT1/PGC-1α axis in the control of skeletal muscle mitochondrial biogenesis, and explore possible pharmacological and physiological interventions designed to activate SIRT1 and the SIRT1/PGC-1α axis in order to prevent and/or treat obesity and obesity-related metabolic disease. The current evidence supports a role for therapeutic activation of SIRT1 and the SIRT1/PGC-1α axis by both pharmaceuticals and exercise in the treatment and prevention of metabolic disease. Future research should be directed toward the feasibility of pharmaceutical activation of SIRT1 in humans and refining exercise prescriptions for optimal SIRT1 activation.

Citing Articles

Aging, ROS, and cellular senescence: a trilogy in the progression of liver fibrosis.

Almalki W, Salman Almujri S Biogerontology. 2024; 26(1):10.

PMID: 39546058 DOI: 10.1007/s10522-024-10153-3.

Piceatannol Upregulates SIRT1 Expression in Skeletal Muscle Cells and in Human Whole Blood: In Vitro Assay and a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Trial.

Tanaka K, Kawakami S, Mori S, Yamaguchi T, Saito E, Setoguchi Y Life (Basel). 2024; 14(5).

PMID: 38792610 PMC: 11122325. DOI: 10.3390/life14050589.

Resveratrol as a potential protective compound against skeletal muscle insulin resistance.

Bahramzadeh A, Bolandnazar K, Meshkani R Heliyon. 2023; 9(11):e21305.

PMID: 38027557 PMC: 10660041. DOI: 10.1016/j.heliyon.2023.e21305.

Sex differences in muscle SIRT1 and SIRT3 and exercise + weight loss effects on muscle sirtuins.

Ryan A, Li G Exp Biol Med (Maywood). 2023; 248(4):302-308.

PMID: 36740765 PMC: 10159525. DOI: 10.1177/15353702221142619.

Jiangtang Sanhao formula ameliorates skeletal muscle insulin resistance regulating GLUT4 translocation in diabetic mice.

Ye Z, Ma J, Liu Y, Xu B, Dai X, Fu M Front Pharmacol. 2022; 13:950535.

PMID: 36160420 PMC: 9492927. DOI: 10.3389/fphar.2022.950535.

References

Milne J, Lambert P, Schenk S, Carney D, Smith J, Gagne D . Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007; 450(7170):712-6. PMC: 2753457. DOI: 10.1038/nature06261. View

Hawley J, Gibala M . Exercise intensity and insulin sensitivity: how low can you go?. Diabetologia. 2009; 52(9):1709-13. DOI: 10.1007/s00125-009-1425-5. View

Lau D, Douketis J, Morrison K, Hramiak I, Sharma A, Ur E . 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ. 2007; 176(8):S1-13. PMC: 1839777. DOI: 10.1503/cmaj.061409. View

Kim J, Chen J, Lou Z . DBC1 is a negative regulator of SIRT1. Nature. 2008; 451(7178):583-6. DOI: 10.1038/nature06500. View

Guarente L . Sirtuins as potential targets for metabolic syndrome. Nature. 2006; 444(7121):868-74. DOI: 10.1038/nature05486. View

Bruce C, Thrush A, Mertz V, Bezaire V, Chabowski A, Heigenhauser G . Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab. 2006; 291(1):E99-E107. DOI: 10.1152/ajpendo.00587.2005. View

Warburton D, Nicol C, Bredin S . Health benefits of physical activity: the evidence. CMAJ. 2006; 174(6):801-9. PMC: 1402378. DOI: 10.1503/cmaj.051351. View

Goodpaster B, Theriault R, Watkins S, Kelley D . Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism. 2000; 49(4):467-72. DOI: 10.1016/s0026-0495(00)80010-4. View

Anderson R, Latorre-Esteves M, Neves A, Lavu S, Medvedik O, Taylor C . Yeast life-span extension by calorie restriction is independent of NAD fluctuation. Science. 2003; 302(5653):2124-2126. PMC: 4998187. DOI: 10.1126/science.1088697. View

10.

Howitz K, Bitterman K, Cohen H, Lamming D, Lavu S, Wood J . Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6. DOI: 10.1038/nature01960. View

11.

Kelley D, He J, Menshikova E, Ritov V . Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002; 51(10):2944-50. DOI: 10.2337/diabetes.51.10.2944. View

12.

Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F . Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006; 127(6):1109-22. DOI: 10.1016/j.cell.2006.11.013. View

13.

Little J, Safdar A, Wilkin G, Tarnopolsky M, Gibala M . A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms. J Physiol. 2010; 588(Pt 6):1011-22. PMC: 2849965. DOI: 10.1113/jphysiol.2009.181743. View

14.

Scarpulla R . Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Ann N Y Acad Sci. 2008; 1147:321-34. PMC: 2853241. DOI: 10.1196/annals.1427.006. View

15.

Ferrara N, Rinaldi B, Corbi G, Conti V, Stiuso P, Boccuti S . Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res. 2007; 11(1):139-50. DOI: 10.1089/rej.2007.0576. View

16.

Sauve A, Wolberger C, Schramm V, Boeke J . The biochemistry of sirtuins. Annu Rev Biochem. 2006; 75:435-65. DOI: 10.1146/annurev.biochem.74.082803.133500. View

17.

Timmers S, Schrauwen P, de Vogel J . Muscular diacylglycerol metabolism and insulin resistance. Physiol Behav. 2008; 94(2):242-51. DOI: 10.1016/j.physbeh.2007.12.002. View

18.

Handschin C, Rhee J, Lin J, Tarr P, Spiegelman B . An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A. 2003; 100(12):7111-6. PMC: 165838. DOI: 10.1073/pnas.1232352100. View

19.

Nemoto S, Fergusson M, Finkel T . SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem. 2005; 280(16):16456-60. DOI: 10.1074/jbc.M501485200. View

20.

Boyko E, de Courten M, Zimmet P, Chitson P, Tuomilehto J, Alberti K . Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care. 2000; 23(9):1242-8. DOI: 10.2337/diacare.23.9.1242. View